DSNKY (Daiichinkyo Co) Forward Dividend Yield %: 2.88% (As of Jun. 28, 2026)


DSNKY Daiichi Sankyo Co Ltd DSNKY
73 GF Score
Price $15.85
GF Value $37.98
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Daiichinkyo Co Forward Dividend Yield %?

Daiichinkyo Co DSNKY +0.51% 73 Forward Dividend Yield % is 2.88% as of Jun. 28, 2026. GuruFocus rates DSNKY with a GF Score™ of 73/100 and a GF Value™ of $37.98 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 505 Drug Manufacturers companies, Daiichinkyo Co ranks better than 76.24% on this metric.

As of today (2026-06-28), the Forward Annual Dividend Yield of Daiichinkyo Co is 2.88%.

As of today (2026-06-28), the Trailing Annual Dividend Yield of Daiichinkyo Co is 1.57%.

DSNKY's Forward Dividend Yield % is ranked better than
76.24% of 505 companies
in the Drug Manufacturers industry
Industry Median: 2.14 vs DSNKY: 2.88

Daiichinkyo Co's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

During the past 12 months, Daiichinkyo Co's average Dividends Per Share Growth Rate was 30.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 37.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 26.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 13.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Daiichinkyo Co was 47.40% per year. The lowest was -9.10% per year. And the median was 5.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Daiichinkyo Co  (OTCPK:DSNKY) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Daiichinkyo Co Forward Dividend Yield % Related Terms


DSNKY vs LLY, JNJ, ABBV: Forward Dividend Yield % Comparison

For the Drug Manufacturers - General subindustry, Daiichinkyo Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiichinkyo Co Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daiichinkyo Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Daiichinkyo Co's Forward Dividend Yield % falls into.


DSNKY
73GF Score
Daiichi Sankyo Co Ltd DSNKY
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiichinkyo Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Daiichinkyo Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.2495522025-09-302025-09-302025-12-17Cash Dividendsemi-annuallyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Daiichinkyo Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.499104/15.85
=3.15 %

Current Share Price is $15.85.
Daiichinkyo Co's Dividends per Share for the forward twelve months is calculated as $0.249552 * 2 = $0.499104.

Daiichinkyo Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.249552/15.85
=1.57 %

Current Share Price is $15.85.
Daiichinkyo Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.249552.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 2.88% mean?
Daiichinkyo Co (DSNKY) has a Forward Dividend Yield % of 2.88% as of Jun. 28, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Daiichinkyo Co and its competitors. According to the industry distribution chart, Daiichinkyo Co ranks #120 out of 505 companies in the Drug Manufacturers industry, placing it in the top 23.8%.
Is Daiichinkyo Co's Forward Dividend Yield % too high?
Daiichinkyo Co's current Forward Dividend Yield % is 2.88%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.14. Daiichinkyo Co's value of 2.88% is 34.6% above this industry median. Based on the distribution chart, Daiichinkyo Co ranks #120 out of 505 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Daiichinkyo Co has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiichinkyo Co's Forward Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Daiichinkyo Co ranks #120 out of 505 companies for Forward Dividend Yield %. This places Daiichinkyo Co in the top 24% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.14. Daiichinkyo Co's value of 2.88% is 34.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.14, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiichinkyo Co's current Forward Dividend Yield % of 2.88% is 34.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Daiichinkyo Co and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiichinkyo Co's current Forward Dividend Yield % is 2.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichinkyo Co stock overvalued right now?
Based on GuruFocus' analysis, Daiichinkyo Co (DSNKY) is currently considered Significantly Undervalued. The stock's GF Value™ is $37.98, compared to a current price of $15.85 — trading 58.3% below its estimated fair value. The current Forward Dividend Yield % is 2.88% and 34.6% above the Drug Manufacturers industry median of 2.14. Daiichinkyo Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Daiichinkyo Co (DSNKY), the current Forward Dividend Yield % is 2.88% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichinkyo Co (DSNKY) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichinkyo Co stock appears to be undervalued. The current stock price of $15.85 is trading 58.3% below its estimated GF Value™ of $37.98. GuruFocus considers Daiichinkyo Co to be Significantly Undervalued.

Key valuation signals for DSNKY:

  • Forward Dividend Yield %: 2.88%
  • GF Value™: $37.98 vs. price of $15.85 (58.3% below fair value)
  • GF Score™: 73/100 with 3 warning signs
  • Industry Position: 34.6% above the Drug Manufacturers median (#120 of 505)

No single metric tells the full story. See the DSNKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daiichinkyo Co Business Description

Address 3-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8426
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2024, approximately one quarter of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates, or ADCs. Its lead ADCs are Enhertu (HER2), Datroway (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu was first approved in the US in December 2019, and Datroway was first approved in January 2025.
73GF Score

Get the complete analysis for DSNKY

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.85
Price
$37.98
GF Value